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Studying rats fed high cholesterol diet and a pancreatic β-cell line (Min6), we aimed to determine the
mechanisms by which quercetin protects against cholesterol-induced pancreatic β-cell dysfunction and
impairments in glycemic control. Quercetin prevented the increase in total plasma cholesterol, but only
partially prevented the high cholesterol diet-induced alterations in lipid proﬁle. Quercetin prevented
cholesterol-induced decreases in pancreatic ATP levels and mitochondrial bioenergetic dysfunction in
Min6 cells, including decreases in mitochondrial membrane potentials and coupling efﬁciency in the
mitochondrial respiration (basal and maximal oxygen consumption rate (OCR), ATP-linked OCR and
reserve capacity). Quercetin protected against cholesterol-induced apoptosis of Min6 cells by inhibiting
caspase-3 and -9 activation and cytochrome c release. Quercetin prevented the cholesterol-induced
decrease in antioxidant defence enzymes from pancreas (cytosolic and mitochondrial homogenates) and
Min6 cells and the cholesterol-induced increase of cellular and mitochondrial oxidative status and lipid
peroxidation. Quercetin counteracted the cholesterol-induced activation of the NFκB pathway in the
pancreas and Min6 cells, normalizing the expression of pro-inﬂammatory cytokines. Quercetin inhibited
the cholesterol-induced decrease in sirtuin 1 expression in the pancreas and pancreatic β-cells. Taken
together, the anti-apoptotic, antioxidant and anti-inﬂammatory properties of quercetin, and its ability to
protect and improve mitochondrial bioenergetic function are likely to contribute to its protective action
against cholesterol-induced pancreatic β-cell dysfunction, thereby preserving glucose-stimulated insulin
secretion (GSIS) and glycemic control. Speciﬁcally, the improvement of ATP-linked OCR and the reserve
capacity are important mechanisms for protection of quercetin. In addition, the inhibition of the NFκB
pathway is an important mechanism for the protection of quercetin against cytokine mediated choles-
terol-induced glycemic control impairment. In summary, our data highlight cellular, molecular and
bioenergetic mechanisms underlying quercetin's protective effects on β-cells in vitro and in vivo, and
provide a scientiﬁcally tested foundation upon which quercetin can be developed as a nutraceutical to
preserve β-cell function.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cholesterol plays an important role in pancreatic β-cell dys-
function. Mice with speciﬁc inactivation of ABCA1 (ATP-bindingB.V. This is an open access article u
n, Faculty of Medicine, Uni-
. Carrasco-Pozo).cassette transporter subfamily A member 1), a transporter that
mediates reverse cholesterol efﬂux show impaired glucose toler-
ance and insulin secretion [1,2]. Moreover, a direct link has been
found between elevated cholesterol and reduced insulin secretion
in islets isolated from C57BL/6J mice and in INS-1 rat pancreatic β-
cells [3], as well as in Min6 cells [4], whereby insulin secretion can
be normalized through cholesterol depletion [3]. LDL receptor
deﬁcient mice exhibit hypercholesterolemia with elevated cho-
lesterol levels in pancreatic islets, which is associated with β-cellnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mulated insulin secretion (GSIS) [5]. Given that pancreatic β-cells
are considered to be particularly susceptible to oxidative stress
due to their relatively low antioxidant enzyme content [6], it has
been suggested that cholesterol may induce β-cell dysfunction by
promoting apoptosis through oxidative stress pathways [4,7] and
mitochondrial damage [4,8] and also by altering membrane
ﬂuidity [9]. Although the molecular mechanism underlying cho-
lesterol-induced inﬂammatory damage to β-cells is not well un-
derstood, it has been shown that cholesterol is able to increase
TNF-α (tumor necrosis factor alpha), interleukin-6 (IL-6) and
macrophage colony-stimulating factor (m-CSF) in macrophages
[10], which could contribute to the damage of β-cells.
Quercetin (QUE) is a natural polyphenolic ﬂavonoid which is
believed to have widespread health beneﬁts due to a combination
of its properties. Quercetin can be (a) antioxidant, by free radical
scavenging and induction of antioxidant defence via nuclear factor
(erythroid-derived 2)-like 2 (Nrf2) activation, (b) anti-in-
ﬂammatory through reducing pro- and increasing anti-in-
ﬂammatory cytokines via nuclear factor kappa B (NFκB) inactiva-
tion and (c) anti-apoptotic by modulating JNK (c-Jun N-terminal
kinase) and ERK (extracellular-signal-regulated kinase)-pathways
[11–14]. Recent in vitro evidence showed the mitochondrial pro-
tective effect of QUE, restoring mitochondrial membrane potential
(MMP), ATP levels and complex-I activity altered by indomethacin,
a non-steroidal anti-inﬂammatory drug, in intestinal Caco-2 cells
[15]. Interestingly, compared to other polyphenols like resveratrol,
rutin and epigallocatechin gallate, QUE was the most efﬁcient in
protecting against mitochondrial dysfunction [15]; this could be
due to its ability to enter cells and accumulate in mitochondria
[15,16]. In addition, it has been shown that QUE up-regulates
mitochondrial complex-I activity to protect against programmed
cell death in rotenone model of Parkinson's disease in rats [17].
Quercetin also has been shown to increase markers of mitochon-
drial biogenesis, such as expression of sirtuin 1 (Sirt1), a nicoti-
namide adenosine dinucleotide-dependent histone deacetylase,
and peroxisome proliferator-activated receptor gamma coacti-
vator-1-alpha (PGC-1α), in soleus muscle and brain; these changes
were associated with an improvement in exercise performance
[18].
Cytokine-induced pancreatic β-cell apoptosis is considered the
main mechanism for β-cell death [19]. Cytokine-induced mi-
tochondrial dysfunction through activation of the NFκB-pathway
and oxidative stress may also trigger β-cell death [20–23]. Quer-
cetin has been shown to prevent cytokine-induced pancreatic β-
cell death by counteracting the mitochondrial apoptosis pathway
and NFκB signalling, thereby preserving glucose-stimulated in-
sulin secretion (GSIS) [20–23]. In addition, QUE via the ERK1/2
pathway, protects β-cells against oxidative damage [24]. Over-
expression of Sirt1 in β-cells improves GSIS, while Sirt1 knock-
down results in impaired response to glucose [25]. Given that
impaired GSIS is a hallmark of the transition from the pre-diabetic
to diabetic state [26], QUE has been proposed to be a promising
anti-diabetic agent due to its ability to induce antioxidant effects
through Sirt1. Also, QUE is known to protect β-cells against da-
mage and to ameliorate hyperglycemia in diabetic animals by re-
ducing oxidative stress, preserving β-cell mass, and lowering
plasma glucose and cholesterol levels [27,28]. Based on evidence
that QUE accumulates in mitochondria [15,16], its β-cell protective
effects may rely not only in its anti-inﬂammatory and anti-oxidant
properties, but also on its protection of mitochondrial function.
The present study aimed to determine the mechanism underlying
the protective effect of QUE on the impairment of GSIS in a pan-
creatic β-cell line exposed to cholesterol and glycemic control in
rats fed a high-cholesterol diet. This study addresses the protective
effects of QUE on mitochondrial bioenergetic dysfunction,inﬂammation, oxidative stress and apoptosis induced by high le-
vels of cholesterol.2. Materials and methods
2.1. Animals and diets
The study protocol was approved by the Animal Ethics Com-
mittee of the Faculty of Medicine of the University of Chile (Ap-
proval No. CBA# 0586 FMUCH) and all procedures were performed
in compliance with the Guidelines for Care and Use of Laboratory
Animals at the Faculty of Medicine. Male Wistar rats (90–110 g, 5–6
weeks old) from the Faculty of Medicine were housed in a 12 h
light/dark schedule at room temperature with water ad libitum.
Forty animals were randomly distributed into 5 groups and fed
standard diet (AIN-76A/Clinton-Cybulsky Cholesterol Series #1-
107); standard diet supplemented with quercetin (0.5% w/w);
high-cholesterol (HC) diet (1.25% cholesterol w/w, AIN-76A/Clin-
ton-Cybulsky Cholesterol Series #3-107); or HC diet supplemented
with either quercetin (0.5% w/w) or ezetimibe (0.001% w/w) for
4 weeks (N¼8 rats per group). Ezetimibe blocks Niemann-Pick C1
Like 1 (NPC1L1) protein in the small intestine, a transporter that
mediates cholesterol absorption [29].
2.2. Laboratory determinations and sample collection
Tail blood glucose levels were determined after 12 h-fasted
(from 9 pm) animals after 2 and 4 weeks of treatment using an
Accu-chek glucometer (Roche, Mannheim, Germany). Immediately
afterwards in 4 week treated rats a glucose tolerance test (IPGTT,
2 g/kg.i.p.) was assayed and blood glucose levels were determined
from tail bleeds. Twenty four h after the IPGTT, plasma glucose and
insulin levels were measured using a colorimetric kit and a rat
insulin ELISA kit, respectively. Cholesterol levels were determined
using a colorimetric colestat enzimática AA kit and pro-in-
ﬂammatory cytokines using a magnetic bead Multiplex assay on
plasma obtained from the inferior vena cava under ketamine:xy-
lazine anaesthesia (100 mg/kg:10 mg/kg, i.p.). Lipid proﬁle (LDL,
VLDL and HDL) was performed by Laboratorio Clinico Medicina
Nuclear (Santiago, Chile). Pancreases were removed and stored in
4% paraformaldehyde and embedded in parafﬁn for im-
munohistochemistry. Pancreatic tissue from the same rats was also
stored in RNA later (Thermo Scientiﬁc, MA USA) for gene expres-
sion assays and at 80 °C for biochemical analyses, including the
quantiﬁcation of cholesterol using the Amplexs Red Cholesterol
Assay Kit (Thermo Scientiﬁc, MA USA).
2.3. Cell culture
Min6 cells (p38–p51) were cultured in DMEM (25 mM glucose)
supplemented with 10% heat-inactivated FBS, 100 IU/ml penicillin
and 100 mg/ml streptomycin. All experiments were conducted in
unsupplemented DMEM media. A “water-soluble cholesterol”
containing 47 mg of cholesterol/g solid (molar ratio, 1:6 choles-
terol/ methyl-β-cyclodextrin, Sigma, MO, USA) was used to deliver
cholesterol to the cells [4,8,30,31]. Considering that 5 mM methyl-
β-cyclodextrin depletes cholesterol from membranes [30,32], a
ten-time lower concentration was used.
2.4. Insulin detection and secretion assays
For immunohistochemistry, pancreatic sections (8 mm) were
deparafﬁnized and antigens retrieved (EDTA 10 mM pH 8, 96 °C/
20 min). Sections were incubated with antibodies against insulin
(ab7842, 1:100, Abcam, UK), and Alexa Fluor488-conjugated
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nuclei stained with DAPI. Fluorescence was visualized with a
ﬂuorescence microscope (AxioScope A1, Zeiss, Germany) equipped
with a digital camera (Canon EOS Rebel T3, Japan). The mean
ﬂuorescence intensity was obtained using ImageJ (NIH Image,
http://www.scioncorp.com, Scion Corporation, USA). The area of
6–8 sections per sample was measured [33]. Fluorescence was
normalized to the islet size and tissue area and to background
ﬂuorescence.
Min6 cells (p38–41) were incubated with cholesterol and/or
QUE for 6 h, in serum-free and glucose-free DMEM. Cells were
placed in serum free DMEM with high glucose (25 mM) for 1 h and
insulin levels in the medium were measured using a Rat Ultra-
sensitive Insulin ELISA kit. Basal insulin secretion in the absence of
glucose was also measured.
2.5. Cell viability quantiﬁcation
Cell viability was assessed with the MTS assay (CellTiter 96s
AQueous assay,) and by lactate dehydrogenase (LDH) release (Cy-
toTox-ONE™ assay, both from Promega, WI, USA) in 96-well plates
[4].
2.6. Apoptosis measurements
Apoptosis was assayed by measuring the activities of caspase-3
and -9, cytochrome c release and DNA fragmentation in cells
plated in 6-well plates. The catalytic activity of caspase-3 and
caspase-9 was colorimetrically determined using a kit from Mil-
lipore (MA, USA). To conﬁrm the speciﬁc induction of the activities
of the caspases by cholesterol, samples were also incubated for
10 min with Ac-DEVD-CHO or Ac-LEHD-CHO, speciﬁc caspase-3
and caspase-9 inhibitors, respectively [4,15]. Cytochrome c was
measured using an ELISA assay (Life Technologies, CA, USA) [15].
DNA fragmentation was assessed by terminal deoxynucleotide
transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) cou-
pled to FITC ﬂuorescence (in situ Cell Death Detection Kit, Roche,
Penzberg, Germany) [4]. Cells treated with DNase I served as po-
sitive controls. The mean ﬂuorescence intensity was obtained with
ImageJ. Images were captured in ﬁelds with 50% conﬂuence based
on DAPI staining (0.15 μg/ml).
2.7. Mitochondrial function studies
Mitochondrial function was assayed in cells in 24-well plates.
MMP was evaluated using Rhod 123 [4]. ATP levels were measured
using the CellTiter-Glo kit [4,34]. Oxygen consumption rates (OCR)
were evaluated with an oxygraph using a Clark-type polarographic
electrode (Warner Instruments, Hamden, CT, USA) and an XFe96
Extracellular Flux Analyzer (Seahorse Bioscience, MA, USA). After
treatment, cells were placed in a microchamber with media con-
taining 200 mM mannitol, 5 mM KH2PO4, 2.5 mM MgCl2, 20 mM
HEPES and 0.5 mM EGTA pH 7.4 and basal OCR was registered in
the oxygraph. After treatment, cells plated in XFe96 were in-
cubated for 1 h at 37 °C in XF Assay Modiﬁed Medium (25 mM
glucose, 2 mM L-glutamine, 2 mM pyruvate, pH 7.4). Rotenone
plus antimycin A (1 μM each) were added to block complex I and
III to determine the non-mitochondrial OCR, which was subtracted
before calculations of mitochondrial parameters [35]. Basal OCR
(state 3), state 4o (induced with 2 μM oligomycin, an ATP synthase
inhibitor) and maximal OCR (State 3u, stimulated with 1.5 μM
FCCP, a mitochondrial inner membrane uncoupler that allows for
maximum electron ﬂux through the electron transport chain)
were sequentially measured. Maximal OCR, reserve capacity (State
3u- State3) and ATP-linked OCR (State 3-state 4o), the difference
between the basal OCR and the oligomycin-insensitive OCR yieldsthe amount of oxygen consumption that is ATP-linked) were cal-
culated as previously described [35]. Reserve capacity is deﬁned as
the amount of oxygen consumption that is available for cells to use
in times of increased ATP demand or during other stress [35,36].
2.8. Cellular redox status and antioxidant defences evaluation
Cells in 24-well plates were pre-incubated for 30 min with
50 mM dichlorodihydroﬂuorescein diacetate (DCFD), 10 μM dihy-
droethidium (DHE) or 5 μM MitoSox™ for the detection of in-
tracellular reactive oxygen species (ROS), superoxide radicals and
mitochondrial superoxide radical production, respectively, and
then incubated with cholesterol and/or QUE. DHE and MitoSox™
Red assays were also conducted in the presence of SOD (100 U/ml)
as a negative control for superoxide radical-dependent oxidation.
Oxidative stress in pancreas and Min6 cells was evaluated by
measuring lipid peroxidation using a TBARS assay kit (Cayman
Chemicals, MI, USA).
SOD and GSH peroxidase activities were determined using
colorimetric kit assays (Cayman). Cytosolic and mitochondria ex-
tracts were prepared as previously described [37].
2.9. qPCR measurements
The mRNA levels of Sirt1, PGC-1α, PPAR γ and LXRα were
evaluated by qPCR [38]. The relative fold expression of each gene is
relative to the cycle thresholds of two housekeeping genes, Actb
and GADPH for pancreas, and Hmbs and Tbp for Min6 cells. Primer
sequences are provided in supplementary Table 1.
2.10. Inﬂammatory status evaluation
Cytokines were measured in rat plasma and in Min6 cell
homogenates using the RECYTMAG-65K and MCYTOMAG-70K
Cytokine/Chemokine Magnetic Bead Panel (EMD Millipore Cor-
poration, MI, USA). To evaluate NFκB translocation, nuclei were
extracted from Min6 cells and pancreatic tissue and an NFκB (p65)
Transcription Factor Assay Kit was used to assess NFκB p50 and
p65 DNA binding activities (Cayman).
2.11. Statistical analysis
Data were analyzed by one-way or two-way ANOVA, followed
by Bonferroni´s Multiple Comparison Test using GraphPad Prism 6
(La Jolla, CA, USA). Unless indicated otherwise, the experiments
were performed three times (three independent culture prepara-
tions for the in vitro studies) and in triplicate or quadruplicate.
Values are expressed as mean 7 SEM.3. Results
3.1. Quercetin prevented cholesterol-induced alterations in glycemic
control
Four weeks of high-cholesterol (HC) feeding in rats resulted in
a 74% increase in total plasma cholesterol levels and a 161% in-
crease in the amount of cholesterol in pancreatic tissue (two-way
ANOVA, post-tests po0.001, Fig. 1A and supplementary Fig. 1, all
n¼8 rats/group). HC increased the LDL and VLDL plasma levels by
114% and 100%, respectively and reduced the HDL plasma levels by
63% (all two-way ANOVA, post-test po0.001, Fig. 1B-D, all n¼8
rats/group). The HC diet increased plasma glucose levels in fasted
rats by 36% and the AUC after the IPGTT by 47% relative to the
control diet (all two-way ANOVAs, post-tests po0.001, Fig. 1E and
po0.01 Fig. 1G, all n¼8 rats/group). In fasted rats, the HC diet
Fig. 1. Quercetin protects against the alteration on glucose and insulin levels in plasma, and pancreatic islet insulin levels induced by a high cholesterol diet and against
impairments of glucose-stimulated insulin secretion in Min6 cells exposed to cholesterol. Rats were fed for 4 weeks with control diet (C), control diet containing 0.5%
quercetin (CQ), high cholesterol diet (HC) or high cholesterol diet containing 0.5% quercetin (HCQ). A) Plasma glucose levels were measured after 12 h fasting. B) Results of an
intraperitoneal glucose tolerance test are shown for rats fed C diet (), CQ ( ), HC ( ) and HCQ ( ), in which plasma glucose levels were recorded at 0, 15, 30, 60, 120 and
150 min after glucose ip. injection and C) the area under the curve (AUC) was calculated. D) Insulin levels in plasma and E) in pancreatic islets were measured after 12 h
fasting. The ﬂuorescence of the insulin was normalized to the Islet and tissue areas. Values are expressed as mean 7 SEM. N¼6–8 rats/group. F) Insulin levels in the media of
Min6 cells were determined in response to glucose (25 mM, for 1 h) after 6 h incubation with 320 mM cholesterol (Chol) and/or 50 mM QUE. Values are expressed as mean 7
SEM, from three independent culture preparations, each treatment performed in quadruplicate. All two-way ANOVAs, symbols indicate Bonferroni post-test signiﬁcances
#relative to control diet and *to HC diet or #relative to control and *to cholesterol-treated Min6 cells.
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test po0.001, n¼8 rats/group, Fig. 1H) and total insulin in islets of
Langerhans by 25% compared to the control diet (t test p¼0.006,
n¼8 rats/group, Fig. 1I and supplementary Fig. 2). Quercetin to-
tally prevented the HC-induced alteration in the plasma levels of
cholesterol, glucose and insulin as well as the pancreatic choles-
terol content (post-test relative to HC diet po0.001, Fig. 1A;
po0.01, Fig. 1B and 1D; po0.05, Fig. 1E; po0.001, Fig. 1F; and
po0.01, supplementary Fig. 1). However, QUE only prevented the
increase in LDL by 57% and VLDL by 59% (all two-way ANOVA,
post-test po0.05 respect to Control diet and po0.01 respect to
HC diet, Fig. 1B and C) and prevented the decrease in HDL by 25%
(two-way ANOVA, post-test po0.001 respect to Control diet and
po0.05 respect to HC diet, Fig. 1D). Quercetin had no effect when
supplemented to rats in the control diet, but it increased the in-
sulin amounts in islets by 35% (post-test relative to C diet po0.05,
Fig. 1F and supplementary Fig. 2).
Ezetimibe completely inhibited the effects of HC feeding on the
plasma levels of total cholesterol, basal glucose and insulin in fasted
rats as well as it prevented the increase in the amount of cholesterolin pancreatic tissue (Supplementary Fig. 3A-D). Ezetimibe also pre-
vented the alteration in lipid proﬁle and the slightly decrease in total
insulin in islets induced by the HC diet (data not shown). The data for
fasting glucose and insulin levels in the ﬁve tested groups were re-
produced in a second batch of 40 animals. After 2 weeks adminis-
tration of HC diet the fasting glucose levels was not signiﬁcant dif-
ferent to those with the control diet (data not shown).
Exposure of Min6 cells to cholesterol caused a 42% decrease in
GSIS (two-way ANOVA, post-test po0.01, Fig. 1J), which was
completely prevented by QUE (post-test relative to cholesterol
po0.01). Basal secretion of insulin (without glucose) was
570.09 ng/mg protein and was increased 10-fold in response to
25 mM glucose. Altogether, our data suggest that QUE improves
glycemic control preventing the cholesterol-induced GSIS impair-
ments in β-cells.
3.2. Quercetin protected against cholesterol-induced loss of cell
viability
Cholesterol decreased the capacity of Min6 cells to reduce MTS
cells by 50% and increased the leakage of LDH into the cell culture
Fig. 2. Quercetin protects against cholesterol-induced decrease in Min6 cell viability. Cell viability was assessed through (A) changes in cellular MTS reduction and
(B) release of LDH into the media. Cells were incubated for 6 h with 320 mM cholesterol and/or 10–100 mMQUE. MTS reductionwas measured in attached cells and LDH in the
supernatant. Values are expressed as mean 7 SEM, from three independent culture preparations, each treatment performed in quadruplicate. All one-way ANOVA (p values
speciﬁed in results), symbols indicate Bonferroni post-test signiﬁcances #in comparison to control and * to cholesterol-treated Min6 cells.
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way ANOVAs po0.001, post-tests po0.001, Fig. 2A and B).
Quercetin attenuated the effects of cholesterol in a concentration
dependent manner from 10 to 50 mM. The cholesterol-induced
cytotoxicity was partially prevented by 10 mM QUE (post-test re-
lative to cholesterol and control po0.01, Fig. 2A and po0.001,
Fig. 2B) and completely prevented by 50 mM QUE (po0.001,
Fig. 2A and B).
3.3. Quercetin inhibited cholesterol-induced apoptosis
Cholesterol increased the activities of caspase-3 by 140% and
caspase-9 by 137% as well as the cytochrome c release by 82%
when compared to the control Min6 cells (all one-way ANOVAs
po0.001, post-tests po0.001, Fig. 3A-C). DNA fragmentation was
enhanced by 120% relative to the control cells (one-way ANOVA
po0.001, post-test po0.001, Fig. 3D and E). Quercetin prevented
these increases in caspase activities and cytochrome c release in a
concentration-dependent manner. Complete attenuation of cho-
lesterol-induced apoptosis was achieved with 50 mM QUE (post-
test relative to cholesterol po0.001, all parameters, Fig. 3A-E). In
the presence of DEVD-CHO or LEHD-CHO, inhibitors or caspases-3
and 9 respectively, cholesterol did not cause caspase activation
(Fig. 3A and B).
3.4. Quercetin prevented cholesterol-induced mitochondrial bioe-
nergetic dysfunction
HC diet decreased the ATP levels in pancreatic tissue by 43%
compared to the control diet (two-way ANOVA, post-test po0.05,
n¼8 rats/group, Fig. 4A), which was completely prevented with
QUE supplementation (post-test relative to HC diet po0.05,
Fig. 4A). Adding QUE to the control diet caused no changes in ATP
levels (Fig. 4A). Ezetimibe also fully inhibited the HC-induced drop
in pancreatic ATP levels (data not shown). Cholesterol decreased
the ATP levels in Min6 cells by 32% and the MMP by 48% when
compared to the control cells (one-way ANOVAs po0.001, post-
tests po0.01, Fig. 4B and po0.001, Fig. 4C). 10 mM QUEcompletely protected against the cholesterol-induced decrease in
ATP levels (post-test relative to cholesterol po0.05, Fig. 4B) and
partially against the decrease of MMP in Min6 cells (post-test re-
lative to cholesterol and to control po0.05, Fig. 4C); while com-
plete protection was achieved at 50 mM QUE (post-test relative to
cholesterol po0.001, Fig. 4C). An example of a coupling assay
measuring OCR using the XFe96 Analyzer is shown in Fig. 4D.
Cholesterol decreased basal OCR by 40%, maximal OCR by 38%,
ATP-linked OCR by 63% and reserve capacity by 62% in Min6 cells
compared to the control (all two-way ANOVAs, post-tests po0.01,
Fig. 4E-H). Ten mM QUE prevented the mitochondrial OCR im-
pairments induced by cholesterol, while by itself also improved
the basal and maximal OCRs, ATP-linked OCR and the reserve ca-
pacity by 41%, 26%, 100% and 83%, respectively (post-test relative
to cholesterol and to control po0.01, Fig. 4E-H). The basal OCRs
obtained from the XFe96 Analyzer (Fig. 4E) were reproduced by
polarography (data not shown).
3.5. Quercetin reduced cholesterol-induced oxidative stress
Cholesterol increased the levels of intracellular ROS by 120%,
cytosolic superoxide radicals by 122%, mitochondrial superoxide
radicals by 168%, lipid peroxidation by 88% in Min6 cells when
compared to control (all one-way ANOVAs po0.001; post-tests
po0.001, Fig. 5A-D). HC diet also increased lipid peroxidation by
122% in pancreas (two-way ANOVA, post-test po0.001, Fig. 1E, all
n¼8 rats/group). While QUE had no effect on these measurements
in the absence of cholesterol, it prevented the oxidative stress and
lipid peroxidation induced by cholesterol in a concentration-de-
pendent manner in Min6 cells. Ten mM was sufﬁcient to com-
pletely prevented these oxidative stress indicators (post-test re-
lative to cholesterol po0.001, all parameters, Fig. 5A-C; po0.05,
Fig. 5D). Quercetin also prevented the lipid peroxidation induced
by HC diet in pancreas (post-test relative to cholesterol po0.001,
Fig. 5E). In the presence of SOD, cholesterol did not oxidise DHE
and MitoSox probes (Fig. 5B and C), indicating that in Min6 cells
cholesterol promotes the production of superoxide radicals which
selectively oxidise the used probes.
Fig. 3. Quercetin protects against cholesterol-induced apoptosis of Min6 cells. The activities of (A) caspase-3 and (B) caspase-9 were measured after 6 h incubation with
320 mM cholesterol and/or 10–100 mM QUE. Cholesterol was also incubated with speciﬁc caspase inhibitors, DEVD-CHO and LEHD-CHO, respectively. (C) Cytochrome c
release was quantiﬁed in media from cells treated for 6 h with 320 mM cholesterol and/or 10–100 mM QUE. (D) TUNEL staining after 6 h incubation with 320 mM cholesterol
and/or 50 mM QUE. (E) Quantiﬁcation of DNA fragmentation. Values are expressed as mean 7 SEM, from three independent culture preparations, each treatment performed
in triplicate. All one-way ANOVA (p values speciﬁed in results), symbols indicate Bonferroni post-test signiﬁcances #relative to control and *to cholesterol-treated Min6 cells.
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defences
In the pancreas, HC diet decreased cytosolic activities of
SOD by 70% and GSH peroxidase by 69%, when compared to
the control diet (all two-way ANOVAs, post-tests po0.01,
Fig. 6A and po0.05, Fig. 6B, all n¼8 rats/group). HC diet also
decreased the mitochondrial activities of SOD and GSH per-
oxidase by 65% and 62% respectively (two-way ANOVA, post-
test po0.01, n¼8 rats/group, Fig. 6C and D). Quercetin com-
pletely prevented the HC-induced decrease in antioxidant
enzyme activities (post-tests relative to HC diet po0.001,
Fig. 6A; po0.01, Fig. 6B and D; po0.05, Fig. 6C). Similar to
QUE, Ezetimibe also completely prevented the effects of HC on
the antioxidant enzymatic activities in pancreatic tissue (data
not shown).
In Min6 cells, cholesterol decreased the total activity of SOD by
57% and GSH peroxidase by 48% when compared to control Min6
cells (all one-way ANOVAs po0.001, post-tests po0.05, Fig. 6E,
and po0.01 Fig. 6F). Quercetin (10 mM) completely reversed the
decrease in the antioxidant enzyme activities induced by choles-
terol (post-tests relative to cholesterol po0.01, Fig. 6E and
po0.05, Fig. 6F).3.7. Quercetin decreased cholesterol-induced inﬂammation
When compared to control diet, the HC diet caused a 140%
increase in NFκB translocation to the nucleus in pancreas (two-
way ANOVA, post-test po0.01, n¼8 rats/group, Fig. 7A) and an
increase in the expression of cytokines downstream of NFκB ac-
tivation (Table 1). The HC diet increased the plasma levels of IL-1β
by 151% TNF-α by 72%, IFN-γ by 49% and granulocyte-macrophage
colony-stimulating factor (GM-CSF) by 946% (all two-way ANOVAs,
post-tests po0.01, n¼6–8 rats/group, Table 1). Quercetin pre-
vented the HC-induced increase in pancreatic NFκB translocation
(post-test relative to HC diet po0.05, Fig. 7A) and in pro-in-
ﬂammatory cytokine levels in plasma (post-test relative to HC diet
po0.001, IL-1β; po0.05, TNF-α; po0.001, IFN-γ; po0.01, GM-
CSF; Table 1). Quercetin had no effect when added to the control
diet (Fig. 7A and Table 1). Ezetimibe totally prevented the in-
ﬂammatory effect of HC in NFκB activation and cytokine levels
(data not shown).
In Min6 cells cholesterol increased the NFκB translocation to
the nucleus by 39% (one-way ANOVA p¼0.0002, post-test
po0.05, Fig. 7B) and the levels of IL-1β by 14%, TNF-α by 15%, IFN-
γ by 19% and GM-CSF by 42% when compared to the control Min6
cells (two-way ANOVAs, post-tests po0.05, Table 1). At 10 mM,
QUE was able to completely inhibit the increase in NFκB translo-
cation (post-test relative to cholesterol po0.05, Fig. 7B). At 50 mM,
Fig. 4. Quercetin protects against the decrease in ATP levels in pancreas of rats fed high cholesterol diet and mitochondrial dysfunction in Min6 cells exposed to cholesterol.
Rats were fed for 4 weeks with control diet (C), control diet containing 0.5% quercetin diet (CQ), high cholesterol diet (HC) and high cholesterol diet containing 0.5% quercetin
(HCQ).A) ATP levels were measured in pancreas after 12 h fasting. N¼6–8 rats/group. Two-way ANOVA, symbols indicate Bonferroni post-test signiﬁcances #relative to
control diet and *to HC diet. Min6 cells were incubated with 320 mM cholesterol and/or 10, 50 or 100 mM QUE. After 6 h B) the ATP, C) MMP levels, and D-H) mitochondrial
respiration parameters were evaluated and expressed as nmol/min/mg prot. (D) Mitochondrial functions were measured in the form of OCR and expressed as nmol of oxygen
consumed/min/mg protein using the Seahorse XFe96 analyzer in control cells () or 6 h-treated cells with: 10 mM QUE ( ), 320 mM cholesterol ( ) or 320 mM cholesterol
(Chol)þ10 mM QUE ( ). (E) Basal OCR and (F) maximal OCR stimulated with FCCP (State 3 u) are shown. (G) ATP-linked OCR was calculated from basal OCR minus the
oligomycin-insensitive OCR. (H) Reserve capacity was calculated as maximal minus basal OCR. Values are expressed as mean 7 SEM, from three independent culture
preparations, each treatment performed in quadruplicate. One-way ANOVAs (B and C, p values speciﬁed in results) and two-way ANOVAs (E-H), symbols indicate Bonferroni
post-test signiﬁcances # in comparison to control and *to cholesterol-treated Min6 cells. Chol, cholesterol; OCR, oxygen consumption rate; RLU, relative luminescence unit.
C. Carrasco-Pozo et al. / Redox Biology 9 (2016) 229–243 235
Fig. 5. Quercetin protects against cholesterol-induced oxidative stress in Min6 cells. After treatment of Min6 cells for 6 h with 320 mM cholesterol and/or 1, 10, 50 or 100 mM
QUE, cellular oxidative status was determined through (A) DCFD oxidation and (B) DHE oxidation. (C) Mitochondrial and oxidative status was determined using MitoSox™
Red oxidation. Oxidative stress was determined by measuring lipid oxidation by TBARS (D) in Min6 cells and (E) in pancreas. Values are expressed as mean7SEM, from three
independent culture preparations, each treatment performed in quadruplicate. All one-way ANOVA (p values speciﬁed in results), symbols indicate Bonferroni post-test
signiﬁcances #relative to control and *to cholesterol-treated Min6 cells. MDA, malondialdehyde.
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Fig. 6. Quercetin protects against the decrease in enzymatic antioxidant defences in the pancreas from rats fed high cholesterol diet and inMin6 cells exposed to cholesterol. In pancreas from
rats fed for 4 weeks with control diet (C), control diet containing 0.5% quercetin diet (CQ), high cholesterol diet (HC) and high cholesterol diet containing 0.5% quercetin (HCQ) the cytosolic
activities of (A) SOD and (B) glutathione peroxidase, and the mitochondrial activities of (C) SOD and (D) glutathione peroxidase were assessed after 12 h fasting. N¼6–8 rats/group. Two-way
ANOVAs (A-D), symbols indicate Bonferroni post-test signiﬁcances #relative to control diet and *to HC diet. In cells incubated for 6 h with320 mM cholesterol and/or 10 or 50 QUE, the (E) SOD
and (F) glutathione peroxidase activities were measured in the whole cell homogenate. Values are expressed as mean7SEM, from three independent culture preparations, each treatment
performed in quadruplicate. One-way ANOVAs (p values speciﬁed in results), symbols indicate Bonferroni post-test signiﬁcances #with respect to control and *to cholesterol-treatedMin6 cells.
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Fig. 7. Quercetin protects against the increase in NFκB translocation to the nucleus in the pancreas from rats fed high cholesterol diet and in Min6 cells exposed to
cholesterol. Nuclear extracts from A) pancreas of rats fed for 4 weeks with control diet (C), control diet containing 0.5% quercetin (CQ), high cholesterol diet (HC) and high
cholesterol diet containing 0.5% quercetin (HCQ) and B) nuclear extracts from cells incubated for 6 h with 320 mM cholesterol and/or 50 mM QUE and NFκB (p65) were
quantiﬁed. Values are expressed as percentage relative to positive control (HeLa cell lysate containing TNFα-activated NFκB (p65), 100%). Values are expressed as
mean7SEM. N¼6–8 rats/group. In the vitro study three independent culture preparations were assessed, in which each treatment was performed in quadruplicate. All two-
way ANOVAs, symbols indicate Bonferroni post-test signiﬁcances #compared to control diet and *to HC diet; or #relative to control and *to cholesterol-treated Min6 cells.
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levels (post-test relative to cholesterol po0.01, IL-1β and IFN- γ;
po0.05, TNF-α; po0.001g-CSF; Table 1). In the absence of cho-
lesterol, QUE had no effect in most of these pro-inﬂammatory
parameters (Fig. 7B and Table 1). Quercetin, with or without
cholesterol, caused a decrease in GM-CSF levels by around 20%
(post-test relative to control po0.001).
Cholesterol and QUE did not alter the plasma levels of these
pro-inﬂammatory cytokines: IL-1α, IL-6, macrophage in-
ﬂammatory protein 1 alpha (MIP-1α) and keratinocyte-derived
chemokine (KC) in Min6 cells (data not shown). Quercetin, with
and without cholesterol, decreased the plasma levels of IL-12 by
16%, monocyte chemoattractant protein-1 (MCP-1) by 14%, IL-5 by
30%, IL-7 by 16% and MIP-2 by 44% approximately in Min6 cells
(data not shown).Table 1
Quercetin prevents the increase of cytokines induced by cholesterol: in vivo and in vitro
Plasma
pg cytokines/ml plasma C CQ
IL-1β 15.5475.52 4.9171.54***
TNF-α 1.6370.28 1.7970.29*
IFN-γ 42.9172.36 35.1371.01*
GM-CSF 3.3970.76 3.4770.76*
Min6 cells
pg cytokines/mg protein Control Quercetin 50 lM
IL-1β 70.3070.97 73.9771.39*
TNF-α 13.0670.34 13.0270.46*
IFN-γ 29.9470.69 30.6470.99*
GM-CSF 119.172.01 92.3675.12***,##
Pro-inﬂammatory markers in plasma from rats fed control diet (C), control diet containing
0.5% quercetin (HCQ). Values are expressed as mean7SEM. N¼6–8 rats/group.
Pro-inﬂammatory markers in Min6 cells treated for 20 h with 320 mM cholesterol and/o
preparations, each treatment performed in quadruplicate. All two-way ANOVA, symbols
cholesterol.*po0.05, **po0.01, ***po0.001; #po0.05, ##po0.01, ###po0.001.3.8. Quercetin modulated cholesterol-induced alteration in gene
expression
Compared to control diet, the HC diet decreased the expression
of Sirt1 by 87% (two-way ANOVA, post-test po0.001, Table 2) and
increased the expression of PGC-1α by 98% (two-way ANOVA,
post-test po0.05, Table 2), PPAR γ by 68% (two-way ANOVA, post-
test po0.01, Table 2) and LXRα by 89% (two-way ANOVA, post-test
po0.01, Table 2). The QUE supplemented control diet (CQ) in-
creased the expression of Sirt1 and PGC-1α by 54% and 154% re-
lative to control diet, respectively (post-test relative to control diet
po0.01, Sirt1 and po0.05, PGC-1α, Table 2). When added to the
HC diet, QUE (HCQ) increased the expression of Sirt1 and PGC-1α
by 51% and 230% respectively when compared to the control diet
(post-test relative to control diet po0.05, Sirt1 and po0.001, PGC-
1α, Table 2) and by 288% and 67% when compared to HC dietstudies.
HC HCQ
38.9377.11## 2.6371.33***
2.8170.24## 1.9470.28*
63.8178.65# 25.0676.34***
35.49712.45## 2.8870.10**
Cholesterol 320 lM Quercetin 50 lMþCholesterol 320 lM
79.8670.63### 73.0571.33**
15.0470.44## 13.4470.18*
35.5471.54# 29.1271.67**
168.672.30### 93.6776.02***,##
0.5% quercetin (CQ), high cholesterol diet (HC) and high cholesterol diet containing
r 50 mM QUE. Values are expressed as mean7SEM, from three independent culture
indicate Bonferroni post-test signiﬁcances #in comparison to control and *to (high)-
Table 2
Quercetin and cholesterol modulate gene expression: in vivo and in vitro studies.
Pancreas
Gene [relative fold expression] C CQ HC HCQ
Sirt1 1.0070.07 1.5470.15***,## 0.1370.07### 1.5170.12***,#
PGC-1α 1.0070.19 2.5470.50**,# 1.9870.11# 3.3070.36**,###
PPAR γ 1.0070.13 0.3070.02***,## 1.6870.21## 1.1570.03*
LXRα 1.0070.11 0.3070.07***,# 1.8970.31## 0.9970.06**
Min6 cells
Gene [relative fold expression] Control Quercetin 50 lM Cholesterol 320 lM Quercetin 50 lM þ Cholesterol 320 lM
Sirt1 1.0070.02 1.3570.07***,### 0.8970.04# 1.3370.12***,###
PGC-1α 1.0070.09 1.6670.18### 1.4670.20## 2.3870.09***,###
PPAR γ 1.0070.26 0.8870.07*** 1.7770.17### 1.3770.03*,#
Gene expression in plasma from rats fed control diet (C), control diet containing 0.5% quercetin (CQ), high cholesterol diet (HC) and high cholesterol diet containing 0.5%
quercetin (HCQ). Values are expressed as mean 7 SEM. N¼6–8 rats/group.
Gene expression in Min6 cells treated for 20 h with 320 mM cholesterol and/or 50 mM QUE. Values are expressed as mean 7 SEM, from three independent culture pre-
parations, each treatment performed in quadruplicate. All two-way ANOVA, symbols indicate Bonferroni post-test signiﬁcances #in comparison to control and *to (high)-
cholesterol.*po0.05, **po0.01, ***po0.001; #po0.05, ##po0.01, ###po0.001.
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Table 2). Quercetin was able to block the HC-induced increase of
PPAR γ (post-test relative to HC diet po0.05, Table 2) and LXRα
expression (post-test relative to HC diet po0.01, Table 2). Fur-
thermore, QUE decreased the expressions of PPAR γ and LXRα by
70% (post-test relative to control diet po0.01, PPAR γ and po0.05,
LXRα, Table 2). All gene expression from the HC diet supplemented
with ezetimibe was not signiﬁcantly different to the control group
(data not shown). Cholesterol and QUE had no effect in IL-12
plasma levels (data not shown).
Compared to control, Min6 cells treated with cholesterol had
decreased Sirt1 expression by 11% (two-way ANOVA, post-test
po0.05, Table 2); while QUE increased its expression by around
35%, either in the presence or absence of cholesterol (two-way
ANOVA, post-test relative to control and cholesterol po0.001,
Table 2). Cholesterol increased the expression of PGC-1α by 46%
and PPAR γ by 77% (two-way ANOVAs, post-tests po0.01, Table 2).
Quercetin, with and without cholesterol, increased the expression
of PGC-1α by 138% and 67% when compared to the control cells,
respectively (post-test relative to control po0.001, Table 2).
Quercetin almost totally counteracted the increase of PPAR γ ex-
pression induced by cholesterol (post-test relative to cholesterol
and control po0.05, Table 2).4. Discussion
In this study we found that QUE prevented the dysfunctions in
plasma glucose control in rats fed high cholesterol diet and GSIS
impairment in cultured pancreatic β-cells exposed to cholesterol.
Using islets of Langerhans staining, Min6 cells and animal rat
model, we demonstrated that QUE prevented cholesterol-induced
apoptosis, mitochondrial dysfunction, oxidative stress and in-
ﬂammation in both in vitro and in vivo models. Given that type
2 diabetes mellitus has become a major health issue worldwide,
and it is well known that cholesterol plays an important role in
pancreatic β-cell dysfunction by inducing the impairment of GSIS
[3,5,9]. The novel effects of QUE described here increase the in-
terest into QUE as a potential anti-diabetic agent.
4.1. New ﬁnding in this study
Although the effect of high cholesterol diet on cardiovascular
diseases has been widely addressed, its effects on metabolic im-
pairments, speciﬁcally on glycemic control have been scarcely
studied [64–66]. While the antidiabetic effects of QUE have beenshown in a streptozocin model of diabetes in rats [67], our study
addresses for the ﬁrst time the protective effect of QUE against
impairments of glycemic control (fasting and in IPGTT) and insulin
levels induced by HC diet in rats, including the mechanisms in-
volved in pancreas and pancreatic β-cells. Here we demonstrated
for the ﬁrst time that HC diet results in impairments in insulin
secretion/production in the islet of Langerhans, which ultimately
leads to decreased plasma insulin levels and decreased glucose
tolerance. Our study also identiﬁed for the ﬁrst time that choles-
terol alters mitochondrial bioenergetics, importantly reducing
ATP-linked OCR and reserve capacity in Min6 cells. This is sup-
ported by the fact that QUE improved mitochondrial function and
thus, protected against the cholesterol induced GSIS impairment,
presented here as a novel mechanism of protection by this ﬂavo-
noid in insulinoma cells. Although it has been shown that high fat
diet and high fructose diet decrease Sirt1 expression in pancreas
[68], here we describe for the ﬁrst time that high cholesterol also
exerts the same effect in pancreas and in pancreatic β-cells.
Through this mechanism, cholesterol may induce mitochondrial
dysfunction, apoptosis and inﬂammation and thus, promote im-
pairments in blood glucose control. These deleterious effects of
cholesterol were abolished in the presence of QUE, which also
increased Sirt1 expression. Our ﬁndings of altered Sirt1 expression
in pancreas and pancreatic β-cells are also novel.
4.2. Cholesterol alters glycemic control validating of our high cho-
lesterol diet in vivo model
According to our in vivo results, the damaging effect on gly-
cemic control induced by HC diet is attributed to the increased
cholesterol levels in plasma and by the alteration of the lipid
proﬁle, increased LDL and VLDL levels and decreased HDL levels.
The impairments in glycemic and insulin control (in plasma and
islets) (Supplementary Fig. 2C-D) were totally prevented when the
increase in total plasma cholesterol levels (and in consequence the
amount of cholesterol in pancreas) and the alterations in lipid
proﬁle caused by the HC diet was reversed by the supplementation
with ezetimibe (Supplementary Fig. 2A-D), a drug used to treat
hypercholesterolemia that blocks NPC1L1-dependent cholesterol
transport [29]. Quercetin prevented the increase in total plasma
cholesterol induced by HC, but it only partially prevented the al-
terations in lipid proﬁle levels, as it was recently reported in hy-
percholesterolemic Apo E/ mice [39]. Thus, the partial effect of
QUE on preventing the HC diet-induced increase in LDL levels, the
particle that carries the majority of the cholesterol in the blood
and supplies it to the cells, and in VLDL levels, which could be
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QUE on the glycemic control is beyond its effect on controlling
total cholesterol levels. This justiﬁes further evaluation in vitro, in
pancreatic beta cells and in vivo, in pancreas against the damage
induced by cholesterol.
4.3. Quercetin protects against the mitochondrial dysfunction in-
duced by cholesterol
Only 10 mM QUE was required to protect against cholesterol-
induced mitochondrial dysfunction in Min6 (Fig. 4B-H). In line
with the antioxidant potential of QUE, this was the same con-
centration of QUE that completely protected against cholesterol-
induced oxidative stress. The powerful effect of this low con-
centration can be explained by earlier ﬁndings that demonstrate
QUE accumulation in mitochondria, which is likely to confer QUE's
exceptional potency for mitochondrial protection [15,16]. The ef-
fective concentration of QUE in our in vitro study (10–50 mM) is
likely to be reached in vivo, since a bioavailability study in rats fed
0.5% QUE diet (this corresponds to the amount used in our study)
for 10 days found 11878 μM of plasma QUE [40]. In addition, after
30 min of the administration of 50 mg/Kg of QUE to rats (in our
study we used a ten time higher dose), a plasma concentration of
58710 μM was detected [41].
Our results suggest that cholesterol induces mitochondrial
dysfunction by interfering with the electron transport chain (ETC)
and altering the physiological efﬂux of protons from the mi-
tochondrial matrix to the intermembrane space, thereby de-
creasing MMP (Fig. 4C) and interfering with oxygen consumption
[42]. In line with this, we observed a decrease in basal (Fig. 4E) and
maximal OCR (Fig. 4F), ATP-linked OCR (Fig. 4G) and reserve ca-
pacity (Fig. 4H) in Min6 cells that were treated with cholesterol. A
decrease in ATP-linked OCR would indicate either low ATP de-
mand, a lack of substrate availability, or severe damage to the ETC,
which would impede the ﬂow of electrons and result in a lower
OCR [36]. Reduced MMP (Fig. 4C) and ATP levels (Fig. 4A-B) may
trigger mitochondrial swelling by induction of the permeability
transition pore, a key effector of the apoptosis pathway mediating
cytochrome c release [43,44]. Consistent with this, we found that
cholesterol promotes cytochrome c release (Fig. 3C). Importantly,
cytochrome c release has been proposed as a biomarker of mi-
tochondrial dysfunction associated to the intrinsic pathway of
apoptosis [44]. Congruent with this, we found increased activities
of caspase-3 and caspase-9 (Fig. 3A-B), and DNA fragmentation
after cholesterol treatment (Fig. 3D-E). Although the mitochon-
drial dysfunctions induced by cholesterol may promote apoptosis
through the intrinsic pathway, the contribution of the extrinsic
pathway of apoptosis induced by cholesterol through the activa-
tion of death receptors cannot be ruled out [45]. In addition to the
protection against cholesterol-induced apoptosis by the preven-
tion of mitochondrial dysfunction and cytochrome c release, QUE
may exert protective effects by increasing Sirt1 expression. Sirtuin
1 regulates cell survival by deacetylating and inactivating p53 [46],
and by deacetylating Ku70, thus controlling Bax activation [47].
An elevation in the ATP/ADP ratio induces exocytosis of insulin
[48]. Therefore, the observed decrease in ATP levels may con-
tribute to low insulin levels in the plasma of rats supplemented
with the HC diet. This is expected to result in impairments found
in GSIS (Fig. 1G) and glycemic control (Fig. 1B-D). Since the HC diet
caused a higher peak in plasma glucose levels and a larger AUC in
the IPGTT tolerance test, the detrimental effect of HC on glycemic
control appears to be attributed to impairment in insulin pro-
duction and release by the pancreas rather than to insulin re-
sistance by adipocytes and skeletal muscles. However, it cannot be
ruled out that cholesterol, in addition to its detrimental effect on
mitochondrial bioenergetics, may also impair the secretion ofinsulin by altering membrane trafﬁcking involved in insulin re-
lease due to an effect on membrane rigidity [49]. However, as QUE
protected against cholesterol-induced impaired GSIS in a β-cell
line, our data suggest that cholesterol does not directly alter
membrane properties in our experimental conditions.
The conservation of a substantial bioenergetic reserve capacity
is a prospective index of “healthy” mitochondrial populations, it is
essential for resistance to oxidative stress and supplying ATP [36].
The higher reserve capacity in QUE treated cells (Fig. 4H) indicates
that QUE improves the ability of substrate supply/oxidation and
thus ETC to respond to increased energy demand, as well as pro-
viding more resistance to oxidative stress. The latter is highly re-
levant in insulinoma, speciﬁcally under hyperglycemic condition,
as β-cells constantly have an increased energy demand when in-
sulin is released. As QUE accumulates in mitochondria [15,16], and
protects against the inhibition of complex I activity [15], it is
possible that QUE may also exert a beneﬁcial effect directly within
the mitochondria. Unlike synthetic antioxidant conjugated with
triphenylphosphonium (TPPþ), such as MitoQ, MitoTempol, QUE
targets mitochondria without inhibiting oxidative phosphorylation
[50]. The improvement of ATP-linked OCR and the reserve capacity
found here are important mechanisms for the protection by QUE
against the impairments in insulin regulation in plasma and in
pancreas and thus against the dysfunction of GSIS and glycemic
control induced by cholesterol.
Quercetin may also protect against cholesterol-induced mi-
tochondrial dysfunction by increasing Sirt1 expression further ra-
ther than preventing its decrease by cholesterol (Table 2). Sirtuin
1-mediates the regulation of PGC-1α activity by deacetylation [51].
PGC-1α is a key regulator of mitochondrial biogenesis, and it has
been reported to induce several genes involved in the TCA cycle,
antioxidant defense, ETC, as well as mitochondrial transcription
factor A (Tfam), an important factor for mitochondrial DNA
(mtDNA) transcription, translation, and repair [52]. Quercetin
promotes an increase in PGC-1α expression (Table 2), but unlike
that of cholesterol, it may be highly activated by the increased
expression of Sirt1 as evidenced by improved mitochondrial
function observed in the presence of QUE.
In contrast, the increase in PGC-1α expression induced by
cholesterol itself (Table 2) may reﬂect a compensatory mechanism
due to (i) a decreased levels of Sirt1 and thus decreased deacety-
lation and activation of PGC-1α, which is reﬂected by decreased
mitochondrial activity or, (ii) an effort to maintain the energetic
levels of the cell. Similarly, cholesterol induced PPAR γ expression
in Min6 cells (Table 2), which may be an attempt to restore the
mitochondrial bioenergetics by supplying more substrate. Pre-
viously, PPAR γ was shown to improve substrate oxidation and
increase substrate supply through increased β-fatty acid oxidation
[53].
The HC diet alone also increased PPARγ and LXRα expressions in
pancreas (Table 2), which is consistent with an overload of cho-
lesterol in pancreas and an effort of the pancreas to minimize
cholesterol levels. Increased PPARγ expression has been shown to
promote cholesterol efﬂux through LXRα in macrophages [54] and
adipocytes [55]. LXRs act as cholesterol sensors, inducing the
transcription of genes that protect cells from cholesterol overload,
regulating reverse cholesterol transport (RCT), cholesterol bio-
synthesis and cholesterol absorption/excretion [56].
4.4. Quercetin protects against the oxidative stress induced by
cholesterol
We found an increase in superoxide radical levels in the mi-
tochondria in pancreatic β-cells exposed to cholesterol (Fig. 5C).
This is consistent with an incomplete reduction of oxygen to water
in this organelle due to an accumulation of electron donors in the
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(Fig. 4C) and OCR (Fig. 4D-H). The cholesterol-induced increase of
cytosolic superoxide radicals and ROS in general (Fig. 5A,B), may
be due to superoxide radical or hydrogen peroxide leakage from
mitochondria through the permeability transition pore, reduced
ROS scavenging, and/or increased ROS production in the cyto-
plasm. In fact, we found that cholesterol decreased SOD and GSH
peroxidase activity in both the cytosol and mitochondria (Fig. 6).
Although superoxide radicals are not strong oxidants, they are
precursors of hydroxyl radicals, which possess the electrical po-
tential necessary to initiate an oxidative chain reaction. Consistent
with this, we found that cholesterol promoted lipid peroxidation
(Fig. 5D) [57] which, along with a decreased GSH peroxidase ac-
tivity (Fig. 6B,D,F) was also observed in the liver of cholesterol-fed
rats [58].
Oxidative stress damages mtDNA impairing the ability of the
organelle to replace dysfunctional electron transport proteins and
decreasing bioenergetic reserve capacity; promoting ultimately
mitophagic mechanisms [36]. Cholesterol by inducing oxidative
stress may reduce the reserve capacity, promote mitophagy and
thus induce PGC-1α expression, as an attempt to restore the mi-
tochondrial mass.
Quercetin prevented the increase in the oxidant status induced
by cholesterol in the β-cell line (Fig. 5). This effect may be because
by its direct antioxidant properties, inherent to its chemical
structure or in its indirect antioxidant properties through induc-
tion of antioxidant defences through the Nrf2 pathway and by
preventing mitochondrial dysfunction (mentioned above), and its
anti-inﬂammatory activity (discussed below). As previously re-
ported about cholesterol [4], QUE can also activate the Nrf2
pathway, but through different mechanisms. Cholesterol promotes
Nrf2 via oxidative stress since cysteine residue oxidation in Keap1
induces a conformational change that disrupts the Keap1–Nrf2
association [59], while QUE induces post-translational modiﬁca-
tions of Nrf2 via the MAPK pathway [11] to allow Nrf2 transloca-
tion to the nucleus. However, we found that cholesterol inactivates
antioxidant enzymes (Fig. 6), suggesting a failure to restore redox
homeostasis through Nrf2 pathway. Moreover their inactivation in
cytosol and in mitochondria has been reported to be ROS-medi-
ated [60], which is consistent with QUE's protection in SOD and
GSH peroxidase activities, in conjunction with its ability to prevent
ROS production in both cellular compartments. Thus, we conclude
that the decrease in the antioxidant defences induced by choles-
terol exacerbates the oxidative status in the cell, which along with
mitochondrial dysfunction (reduced reserve capacity), promotes
oxidative stress.
4.5. Quercetin protects against inﬂammation induced by cholesterol
Our ﬁnding that cholesterol promoted NFκB activation (Fig. 7)
and increased the expression of several NFκB-regulated cytokines
(Table 1) indicates that NFκB activation underlies cholesterol-in-
duced β-cell GSIS dysfunction and glycemic control impairment.
The decrease in GSIS and the increase in oxidative stress and mi-
tochondrial dysfunction in INS-1 and RINm5F pancreatic β-cells in
the presence of combined cytokines: IL-1β, TNF-α and IFN-γ
[20,23] suggest that cytokines exert synergic detrimental effects
on insulin-secreting cells. The antioxidant properties of QUE may
also contribute to the prevention of cholesterol-induced NFκB
pathway activation observed in this study, since ROS are associated
with NFκB activation through the increase in I-κB degradation
[61].
As QUE increased Sirt1 expression (Table 2), it is possible that
QUE prevents the cholesterol-induced NFκB activation, cytokine
production, and subsequent GSIS and glycemic control impairment
and apoptosis observed in this study via Sirt1. It has been reportedthat Sirt1 inhibits the transcriptional activity of NFκB, by deace-
tylating the RelA/p65 subunit [62] and that overexpression of Sirt1
in mice leads to down-regulated NFκB activity [63] and improved
GSIS in β-cells [25].
The limitation of our study is that we used the whole pancreas
and we did not isolate the islets of Langerhans for our biochemical
studies. Thus, future studies are recommended to conﬁrm the
protective effects of QUE on pancreatic islets in in vivo and ex vivo
models.
In conclusion, our study demonstrates that QUE protects
against cholesterol-induced impairments in β-cell bioenergetics,
thus preventing mitochondrial dysfunction and preserving insulin
exocytosis and glycemic control. The improvement of ATP-linked
OCR and the reserve capacity are important mechanisms of the
protection of QUE against the cholesterol-induced GSIS and gly-
cemic control impairments. Due to its antioxidant and mitochon-
drial protective properties QUE prevented the cholesterol-induced
decrease in antioxidant defences, and the cholesterol-induced in-
crease in cellular and mitochondrial oxidative status, thus pre-
venting oxidative stress. The inhibition of the NFκB pathway is
another important mechanism for the protection of QUE against
cytokine mediated cholesterol-induced GSIS and glycemic control
impairments. The deleterious effects of cholesterol were asso-
ciated with a decrease in Sirt1 expression, while QUE increase in
Sirt1 expression. This study contributes to the elucidation of the
mitochondrial, cellular and molecular mechanisms underlying
cholesterol-induced cytotoxicity in pancreatic β-cells, and the
mitochondrial, cellular and molecular basis for the protective ef-
fects of QUE in vitro and in vivo which can contribute to improved
glycemic control.Author contributions
CC-P designed the experimental study. CC-P, KNT, STN, MR-F,
NdelaJ, PLL performed the experiments. CC-P, KNT, KB and DFG-D
interpreted the results. CC-P, KNT, STN and KB drafted the manu-
script. All authors commented and approved the submitted
manuscript.Acknowledgments
The present study was supported by Fondecyt Initiation into
Research Grant 11130232 to CC-P. We are grateful for support from
IPRS and UQCent scholarships from the University of Queensland
(KNT), and an MNDRIA Bill Gole Postdoctoral Research Fellowship,
and The University of Queensland (STN) and NHMRC project grant
(1044007, KB).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.redox.2016.08.007.References
[1] L.R. Brunham, J.K. Kruit, T.D. Pape, J.M. Timmins, A.Q. Reuwer, Z. Vasanji, B.
J. Marsh, B. Rodrigues, J.D. Johnson, J.S. Parks, C.B. Verchere, M.R. Hayden, Beta-
cell ABCA1 inﬂuences insulin secretion, glucose homeostasis and response to
thiazolidinedione treatment, Nat. Med. 13 (3) (2007) 340–347.
[2] I. Gerin, V.W. Dolinsky, J.G. Shackman, R.T. Kennedy, S.H. Chiang, C.F. Burant, K.
R. Steffensen, J.A. Gustafsson, O.A. MacDougald, LXRbeta is required for adi-
pocyte growth, glucose homeostasis, and beta cell function, J. Biol. Chem. 280
(24) (2005) 23024–23031.
C. Carrasco-Pozo et al. / Redox Biology 9 (2016) 229–243242[3] M. Hao, W.S. Head, S.C. Gunawardana, A.H. Hasty, D.W. Piston, Direct effect of
cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell
dysfunction, Diabetes 56 (9) (2007) 2328–2338.
[4] C. Carrasco-Pozo, M. Gotteland, R.L. Castillo, C. Chen, 3,4-dihydrox-
yphenylacetic acid, a microbiota-derived metabolite of quercetin, protects
against pancreatic beta-cells dysfunction induced by high cholesterol, Exp.
Cell Res. 4 (15) (2015) 00115–00119.
[5] M.L. Bonﬂeur, E.C. Vanzela, R.A. Ribeiro, G. de Gabriel Dorighello, C.P. de Franca
Carvalho, C.B. Collares-Buzato, E.M. Carneiro, A.C. Boschero, H.C. de Oliveira,
Primary hypercholesterolaemia impairs glucose homeostasis and insulin se-
cretion in low-density lipoprotein receptor knockout mice independently of
high-fat diet and obesity, Biochim. Biophys. Acta 1801 (2) (2010) 183–190.
[6] K. Grankvist, S.L. Marklund, I.B. Taljedal, CuZn-superoxide dismutase, Mn-su-
peroxide dismutase, catalase and glutathione peroxidase in pancreatic islets
and other tissues in the mouse, Biochem. J. 199 (2) (1981) 393–398.
[7] X. Lu, J. Liu, F. Hou, Z. Liu, X. Cao, H. Seo, B. Gao, Cholesterol induces pancreatic
beta cell apoptosis through oxidative stress pathway, Cell Stress Chaperon. 16
(5) (2011) 539–548.
[8] Y.F. Zhao, L. Wang, S. Lee, Q. Sun, Y. Tuo, Y. Wang, J. Pei, C. Chen, Cholesterol
induces mitochondrial dysfunction and apoptosis in mouse pancreatic beta-
cell line MIN6 cells, Endocrine 37 (1) (2010) 76–82.
[9] R. Dirkx Jr, M. Solimena, Cholesterol-enriched membrane rafts and insulin
secretion, J. Diabetes Investig. 3 (4) (2012) 339–346.
[10] Y. Li, I. Tabas, The inﬂammatory cytokine response of cholesterol-enriched
macrophages is dampened by stimulated pinocytosis, J. Leukoc. Biol. 81 (2)
(2007) 483–491.
[11] A.B. Granado-Serrano, M.A. Martin, L. Bravo, L. Goya, S. Ramos, Quercetin
modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement
of p38, Chem. Biol. Interact. 195 (2) (2012) 154–164.
[12] M. Hamalainen, R. Nieminen, P. Vuorela, M. Heinonen, E. Moilanen, Anti-in-
ﬂammatory effects of ﬂavonoids: genistein, kaempferol, quercetin, and daid-
zein inhibit STAT-1 and NF-kappaB activations, whereas ﬂavone, iso-
rhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation
along with their inhibitory effect on iNOS expression and NO production in
activated macrophages, Mediat. Inﬂamm. 45673 (10) (2007) 45673.
[13] G.S. Kelly, Quercetin. Monograph, Alter. Med. Rev. 16 (2) (2011) 172–194.
[14] S. Tanigawa, M. Fujii, D.X. Hou, Action of Nrf2 and Keap1 in ARE-mediated
NQO1 expression by quercetin, Free Radic. Biol. Med. 42 (11) (2007)
1690–1703.
[15] C. Carrasco-Pozo, E. Pastene, C. Vergara, M. Zapata, C. Sandoval, M. Gotteland,
Stimulation of cytosolic and mitochondrial calcium mobilization by in-
domethacin in Caco-2 cells: modulation by the polyphenols quercetin, resveratrol
and rutin, Biochimica et biophysica acta 1820(12), 2012 pp. 2052–2061.
[16] M. Fiorani, A. Guidarelli, M. Blasa, C. Azzolini, M. Candiracci, E. Piatti,
O. Cantoni, Mitochondria accumulate large amounts of quercetin: prevention
of mitochondrial damage and release upon oxidation of the extra-
mitochondrial fraction of the ﬂavonoid, J. Nutr. Biochem. 21 (5) (2010)
397–404.
[17] S.S. Karuppagounder, S.K. Madathil, M. Pandey, R. Haobam, U. Rajamma, K.
P. Mohanakumar, Quercetin up-regulates mitochondrial complex-I activity to
protect against programmed cell death in rotenone model of Parkinson's
disease in rats, Neuroscience 236 (2013) 136–148.
[18] J.M. Davis, E.A. Murphy, M.D. Carmichael, B. Davis, Quercetin increases brain
and muscle mitochondrial biogenesis and exercise tolerance, Am. J. Physiol.
Regul. Integr. Comp. Physiol. 296 (4) (2009) 11.
[19] T. Mandrup-Poulsen, Apoptotic signal transduction pathways in diabetes,
Biochem Pharm. 66 (8) (2003) 1433–1440.
[20] X. Dai, Y. Ding, Z. Zhang, X. Cai, Y. Li, Quercetin and quercitrin protect against
cytokineinduced injuries in RINm5F beta-cells via the mitochondrial pathway
and NF-kappaB signaling, Int J. Mol. Med. 31 (1) (2013) 265–271.
[21] E.K. Kim, K.B. Kwon, M.Y. Song, M.J. Han, J.H. Lee, Y.R. Lee, D.G. Ryu, B.H. Park, J.
W. Park, Flavonoids protect against cytokine-induced pancreatic beta-cell
damage through suppression of nuclear factor kappaB activation, Pancreas 35
(4) (2007) e1–e9.
[22] W.H. Kim, J.W. Lee, B. Gao, M.H. Jung, Synergistic activation of JNK/SAPK in-
duced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via
the p53 and ROS pathway, Cell Signal. 17 (12) (2005) 1516–1532.
[23] C.Y. Lin, C.C. Ni, M.C. Yin, C.K. Lii, Flavonoids protect pancreatic beta-cells from
cytokines mediated apoptosis through the activation of PI3-kinase pathway,
Cytokine 59 (1) (2012) 65–71.
[24] E. Youl, G. Bardy, R. Magous, G. Cros, F. Sejalon, A. Virsolvy, S. Richard, J.
F. Quignard, R. Gross, P. Petit, D. Bataille, C. Oiry, Quercetin potentiates insulin
secretion and protects INS-1 pancreatic beta-cells against oxidative damage
via the ERK1/2 pathway, Br. J. Pharm. 161 (4) (2010) 799–814.
[25] K.A. Moynihan, A.A. Grimm, M.M. Plueger, E. Bernal-Mizrachi, E. Ford, C. Cras-
Meneur, M.A. Permutt, S. Imai, Increased dosage of mammalian Sir2 in pan-
creatic beta cells enhances glucose-stimulated insulin secretion in mice, Cell
Metab. 2 (2) (2005) 105–117.
[26] A.G. Tabak, C. Herder, W. Rathmann, E.J. Brunner, M. Kivimaki, Prediabetes: a
high-risk state for diabetes development, Lancet 379 (9833) (2012)
2279–2290.
[27] S.M. Jeong, M.J. Kang, H.N. Choi, J.H. Kim, J.I. Kim, Quercetin ameliorates hy-
perglycemia and dyslipidemia and improves antioxidant status in type 2 dia-
betic db/db mice, Nutr. Res Pract. 6 (3) (2012) 201–207.
[28] J.M. Li, W. Wang, C.Y. Fan, M.X. Wang, X. Zhang, Q.H. Hu, L.D. Kong, Quercetin
preserves beta-cell mass and function in fructose-induced hyperinsulinemiathrough modulating pancreatic Akt/FoxO1 activation, Evid. Based Comple-
ment Altern. Med. 303902 (10) (2013) 27.
[29] N. Katsiki, E. Theocharidou, A. Karagiannis, V.G. Athyros, D.P. Mikhailidis,
Ezetimibe therapy for dyslipidemia: an update, Curr. Pharm. Des. 19 (17)
(2013) 3107–3114.
[30] C.-H. Lai, Y.-C. Chang, S.-Y. Du, H.-J. Wang, C.-H. Kuo, S.-H. Fang, H.-W. Fu, H.-
H. Lin, A.-S. Chiang, W.-C. Wang, Cholesterol depletion reduces helicobacter
pylori CagA translocation and CagA-induced responses in AGS cells, Infect.
Immun. 76 (7) (2008) 3293–3303.
[31] N. Khatibzadeh, A.A. Spector, W.E. Brownell, B. Anvari, Effects of plasma
membrane cholesterol level and cytoskeleton F-actin on cell protrusion me-
chanics, PLoS One 8(2), p. e57147.
[32] W. Ziolkowski, M. Szkatula, A. Nurczyk, T. Wakabayashi, J.J. Kaczor, R.A. Olek,
N. Knap, J. Antosiewicz, M.R. Wieckowski, M. Wozniak, Methyl-beta-cyclo-
dextrin induces mitochondrial cholesterol depletion and alters the mi-
tochondrial structure and bioenergetics, FEBS Letters 584 (22) pp. 4606–4610.
[33] C. Carrasco-Pozo, R.L. Castillo, C. Beltrán, A. Miranda, J. Fuentes, M. Gotteland,
Molecular mechanisms of gastrointestinal protection by quercetin against
indomethacin-induced damage: role of NF-κB and Nrf2, J. Nutr. Biochem. 27
(2016) 289–298.
[34] M. Andriamihaja, A. Lan, M. Beaumont, M. Audebert, X. Wong, K. Yamada,
Y. Yin, D. Tome, C. Carrasco-Pozo, M. Gotteland, X. Kong, F. Blachier, The de-
leterious metabolic and genotoxic effects of the bacterial metabolite p-cresol
on colonic epithelial cells, Free Radic. Biol. Med. 85 (2015) 219–227.
[35] B.P. Dranka, G.A. Benavides, A.R. Diers, S. Giordano, B.R. Zelickson, C. Reily,
L. Zou, J.C. Chatham, B.G. Hill, J. Zhang, A. Landar, V.M. Darley-Usmar, Asses-
sing bioenergetic function in response to oxidative stress by metabolic pro-
ﬁling, Free Radic. Biol. Med. 51 (9) (2011) 1621–1635.
[36] B.G. Hill, G.A. Benavides, J.R. Lancaster, S. Ballinger, L. Dell’Italia, J. Zhang, V.
M. Darley-Usmar, Integration of cellular bioenergetics with mitochondrial
quality control and autophagy, Biol. Chem. 393 (12) (2012) 1485–1512.
[37] C. Carrasco-Pozo, K.N. Tan, K. Borges, Sulforaphane is anticonvulsant and
improves mitochondrial function, J. Neurochem. 135 (5) (2015) 932–942.
[38] M.G. Hadera, O.B. Smeland, T.S. McDonald, K.N. Tan, U. Sonnewald, K. Borges,
Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates
in the mouse pilocarpine model of epilepsy, J. Neurochem. 129 (1) (2014)
107–119, http://dx.doi.org/10.1111/jnc.12610, Epub 2013 Dec 2. (2014).
[39] E. Ulasova, J. Perez, B.G. Hill, W.E. Bradley, D.W. Garber, A. Landar, S. Barnes,
J. Prasain, D.A. Parks, L.J. Dell'Italia, V.M. Darley-Usmar, Quercetin prevents left
ventricular hypertrophy in the Apo E knockout mouse, Redox Biol. 1 (2013)
381–386.
[40] C. Manach, C. Morand, O. Texier, M.L. Favier, G. Agullo, C. Demigne, F. Regerat,
C. Remesy, Quercetin metabolites in plasma of rats fed diets containing rutin
or quercetin, J. Nutr. 125 (7) (1995) 1911–1922.
[41] M.K. Piskula, Factors affecting ﬂavonoids absorption, Biofactors 12 (1–4)
(2000) 175–180.
[42] M.D. Brand, D.G. Nicholls, Assessing mitochondrial dysfunction in cells, Bio-
chem. J. 435 (2) (2011) 297–312.
[43] V. Giorgio, S. von Stockum, M. Antoniel, A. Fabbro, F. Fogolari, M. Forte, G.
D. Glick, V. Petronilli, M. Zoratti, I. Szabo, G. Lippe, P. Bernardi, Dimers of
mitochondrial ATP synthase form the permeability transition pore, Proc. Natl.
Acad. Sci. USA 110 (15) (2013) 5887–5892.
[44] E. Latz, T.S. Xiao, A. Stutz, Activation and regulation of the inﬂammasomes,
Nat. Rev. Immunol. 13 (6) (2013) 397–411.
[45] S.C. Lim, K.R. Parajuli, H.Q. Duong, J.E. Choi, S.I. Han, Cholesterol induces au-
tophagic and apoptotic death in gastric carcinoma cells, Int J. Oncol. 44 (3)
(2014) 805–811.
[46] H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente,
R.A. Weinberg, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase,
Cell 107 (2) (2001) 149–159.
[47] H.Y. Cohen, S. Lavu, K.J. Bitterman, B. Hekking, T.A. Imahiyerobo, C. Miller,
R. Frye, H. Ploegh, B.M. Kessler, D.A. Sinclair, Acetylation of the C terminus of
Ku70 by CBP and PCAF controls Bax-mediated apoptosis, Mol. Cell 13 (5)
(2004) 627–638.
[48] J.C. Hou, L. Min, J.E. Pessin, Insulin granule biogenesis, trafﬁcking and exocy-
tosis, Vitam. Horm. 80 (2009) 473–506.
[49] J.S. Bogan, Y. Xu, M. Hao, Cholesterol accumulation increases insulin granule
size and impairs membrane trafﬁcking, Trafﬁc 13 (11) (2012) 1466–1480.
[50] C. Reily, T. Mitchell, B.K. Chacko, G. Benavides, M.P. Murphy, V. Darley-Usmar,
Mitochondrially targeted compounds and their impact on cellular bioener-
getics, Redox Biol. 1 (1) (2013) 86–93.
[51] P.J. Fernandez-Marcos, J. Auwerx, Regulation of PGC-1α, a nodal regulator of
mitochondrial biogenesis, Am. J. Clin. Nutr. 93 (4) (2011) 884S–890S.
[52] R. Ventura-Clapier, A. Garnier, V. Veksler, Transcriptional control of mi-
tochondrial biogenesis: the central role of PGC-1alpha, Cardiovasc Res. 79 (2)
(2008) 208–217.
[53] F.A. Monsalve, R.D. Pyarasani, F. Delgado-Lopez, R. Moore-Carrasco, Peroxi-
some proliferator-activated receptor targets for the treatment of metabolic
diseases, Mediat. Inﬂamm. 2013 (2013) 549627, http://dx.doi.org/10.1155/
2013/549627, Epub 2013 May 27. (2013).
[54] A.D. Baker, A. Malur, B.P. Barna, M.S. Kavuru, A.G. Malur, M.J. Thomassen,
PPARγ regulates the expression of cholesterol metabolism genes in alveolar
macrophages, Biochem. Biophys. Res. Commun. 393 (4) (2010) 682–687.
[55] S.Z. Dong, S.P. Zhao, Z.H. Wu, J. Yang, X.Z. Xie, B.L. Yu, S. Nie, Curcumin pro-
motes cholesterol efﬂux from adipocytes related to PPARgamma-LXRalpha-
ABCA1 passway, Mol. Cell Biochem. 358 (1–2) (2011) 281–285.
C. Carrasco-Pozo et al. / Redox Biology 9 (2016) 229–243 243[56] C. Zhao, K. Dahlman-Wright, Liver X receptor in cholesterol metabolism, J.
Endocrinol. 204 (3) (2010) 233–240.
[57] J.M. Gutteridge, D.A. Rowley, B. Halliwell, Superoxide-dependent formation of
hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detec-
tion of 'catalytic' iron and anti-oxidant activity in extracellular ﬂuids, Biochem.
J. 206 (3) (1982) 605–609.
[58] A.C. Tsai, Lipid peroxidation and glutathione peroxidase activity in the liver of
cholesterol-fed rats, J. Nutr. 105 (7) (1975) 946–951.
[59] H.K. Bryan, A. Olayanju, C.E. Goldring, B.K. Park, The Nrf2 cell defence path-
way: Keap1-dependent and -independent mechanisms of regulation, Bio-
chem. Pharm. 85 (6) (2013) 705–717.
[60] E. Pigeolet, J. Remacle, Susceptibility of glutathione peroxidase to proteolysis
after oxidative alteration by peroxides and hydroxyl radicals, Free Radic. Biol.
Med 11 (2) (1991) 191–195.
[61] N. Li, M. Karin, Is NF-kappaB the sensor of oxidative stress? FASEB J.: Off. Publ.
Fed. Am. Soc. Exp. Biol. 13 (10) (1999) 1137–1143.
[62] F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, M.W. Mayo,
Modulation of NF-κB‐dependent transcription and cell survival by the SIRT1
deacetylase, EMBO J. 23 (12) (2004) 2369–2380.[63] P.T. Pﬂuger, D. Herranz, S. Velasco-Miguel, M. Serrano, M.H. Tschop, Sirt1
protects against high-fat diet-induced metabolic damage, Proc. Natl. Acad. Sci.
USA 105 (28) (2008) 9793–9798.
[64] H.K. Bryan, A. Olayanju, C.E. Goldring, B.K. Park, The Nrf2 cell defence path-
way: Keap1-dependent and -independent mechanisms of regulation, Bio-
chem. Pharm. 85 (6) (2013) 705–717.
[65] E. Pigeolet, J. Remacle, Susceptibility of glutathione peroxidase to proteolysis
after oxidative alteration by peroxides and hydroxyl radicals, Free Radic. Biol.
Med 11 (2) (1991) 191–195.
[66] N. Li, M. Karin, Is NF-kappaB the sensor of oxidative stress? FASEB J.: Off. Publ.
Fed. Am. Soc. Exp. Biol. 13 (10) (1999) 1137–1143.
[67] F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, M.W. Mayo,
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1
deacetylase, EMBO J. 23 (12) (2004) 2369–2380.
[68] P.T. Pﬂuger, D. Herranz, S. Velasco-Miguel, M. Serrano, M.H. Tschop, Sirt1
protects against high-fat diet-induced metabolic damage, Proc. Natl. Acad. Sci.
USA 105 (28) (2008) 9793–9798.
